期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

艾滋病基础与临床研究进展 被引量：2

原文传递
导出
摘要 艾滋病，即获得性免疫缺陷综合征（AIDs），是由HIV引起的一种传染病。HIV在人体内特异性攻击CD4＋T淋巴细胞，造成免疫系统功能进行性破坏，导致各种机会性感染和肿瘤的发生。自1981年美国报道第一例AIDS至今，AIDS已在世界范围内迅速蔓延，成为威胁人类生存的重大传染病。全球现存HIV／AIDs患者3320万人，仅2007年新发感染即达250万人，有210万人死于AIDS。
作者 曹玮 李太生
机构地区 中国医学科学院北京协和医院感染内科
出处 《中华传染病杂志》 CAS CSCD 北大核心 2009年第4期248-251,共4页 Chinese Journal of Infectious Diseases
关键词 艾滋病 HIV/AIDS患者 临床研究 获得性免疫缺陷综合征 CD4+T淋巴细胞 机会性感染 免疫系统功能 AIDS
分类号 R512.91 [医药卫生—内科学] R392.6 [医药卫生—免疫学]
  • 相关文献

参考文献19

  • 1Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T- cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol, 2003,77:11708-11717.
  • 2Poles MA, Boscardin W3, Elliott J, et al. Lack of decay of HIV-1 in gut associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr, 2006,43:65-68.
  • 3Schacker TW, Reilly C, Beilman GJ, et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. AIDS, 2005,19:2169-2171.
  • 4McCoombe SG, Hope TJ. Fluorescent detection of individual HIV virions within genital tissues. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, 2007, July. Abstract MOPDA05.
  • 5Murray JM, Emery S, Kelleher AD, et al. Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. AIDS, 2007,21:2315-2321.
  • 6May M, Sterne JA, Sabin C, et al. Prognosis of HIV-1- infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS, 2007, 21:1185-1197.
  • 7Emery S for the SMART Study Group and INSIGHT. Major clinical outcomes in patients not treated with antiretroviral therapy (ART) at baseline in SMART: A rationale for a trial to examine early treatment of HIV disease. 4th International AIDS Society Confereaee on HIV Pathogenesis, Treatment and Prevention, Sydney, 2007, July. Abstract WePeB018.
  • 8Mellors JW, Margolick JB, Phair JP,et al. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA, 2007,297 : 2349-2350.
  • 9Gulick RM, van der Ryst E, Lampiris H, et al. Efficacy and safety of once-daily (QD) compared with twice-daily (BID) maraviroc plus optimized background therapy (OBT) in treatment-experienced patients infected with CCR5 tropic- HIV-1: 24 week combined analysis of the MOTIVATE 1 and 2 studies. 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, 2007, July. Abstract WEPEB116LB.
  • 10Cooper D, Gatell J, Rockstroh J, et al. Results from BENCHMRK 1, a phase Ill study evaluating the efficacy and safety of MK-0518, a novel HIV-1 integrase inhibitor, in patients with triple-class resistant virus. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, 2007. February. Abstract 105Alb.

同被引文献18

引证文献2

二级引证文献14

中华传染病杂志
2009年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部